Logo image of AGE

AGEX THERAPEUTICS INC (AGE) Stock Analyst Earnings Estimates

NYSEARCA:AGE - NYSE Arca - US00848H2076 - Common Stock - Currency: USD

11.1  -1.5 (-11.9%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022
Revenue
YoY % growth
AGE revenue by date.AGE revenue by date.
360K
-79.19%		140K
-61.11%		30K
-78.57%
EBITDA
YoY % growth
AGE ebitda by date.AGE ebitda by date.
-8.84M
25.78%		-7.91M
10.52%		-6.85M
13.40%
EBIT
YoY % growth
AGE ebit by date.AGE ebit by date.
-10.1M
19.59%		-8.04M
20.40%		-6.98M
13.18%
Operating Margin
AGE operating margin by date.AGE operating margin by date.
-2,805.56%-5,742.86%-23,266.67%
EPS
YoY % growth
AGE eps by date.AGE eps by date.
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth		 -0.14
-133.33%		%
Q3 2022
Q2Q % growth		 -0.06
-20.00%		%
Q2 2022
Q2Q % growth		 -0.07 %
Q1 2022
Q2Q % growth		 -0.07
-40.00%		%
AGE Yearly EPS VS EstimatesAGE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth		 70K
600.00%		%
Q2 2023
Q2Q % growth		 10K %
Q1 2023
Q2Q % growth		 10K %
Q4 2022
Q2Q % growth		 10K
-66.67%		%
Q3 2022
Q2Q % growth		 10K
-50.00%		%
Q2 2022
Q2Q % growth		 10K
-75.00%		%
Q1 2022
Q2Q % growth		 10K
-83.33%		%
Q4 2021
Q2Q % growth		 30K
-81.25%		%
Q3 2021
Q2Q % growth		 20K
-71.43%		%
Q2 2021
Q2Q % growth		 40K
-20.00%		%
Q1 2021
Q2Q % growth		 60K
-33.33%		%
Q4 2020
Q2Q % growth		 160K
-70.91%		%
Q3 2020
Q2Q % growth		 70K
-82.93%		%
Q2 2020
Q2Q % growth		 50K
-86.84%		%
Q1 2020
Q2Q % growth		 90K
-76.92%		%
AGE Yearly Revenue VS EstimatesAGE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 500K 1M 1.5M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A